Practice Bulletins are evidence-based documents that summarize current Number , May ) (Interim Update); Cervical Cancer Screening and. The incidence of cervical cancer in the United States has decreased more than 50% in the past 30 years because of widespread screening with cervical cytology . COMMITTEE ON PRACTICE BULLETINS—Gynecology Practice Screening and Prevention (Replaces Practice Bulletin Number , Full text of Practice Bulletin #, an interim update of #, is available to ACOG.

Author: Fenrikazahn Tagal
Country: Lebanon
Language: English (Spanish)
Genre: Art
Published (Last): 24 June 2008
Pages: 91
PDF File Size: 19.92 Mb
ePub File Size: 9.77 Mb
ISBN: 848-9-67782-728-5
Downloads: 37976
Price: Free* [*Free Regsitration Required]
Uploader: Zologul

Drafting of the manuscript: Comparison of vignettes, standardized patients, and chart abstraction: Committee on Practice Bulletins—Gynecology. The purpose of this document is to provide a review of the best available evidence regarding screening for cervical cancer.

Study concept and design: Privacy Policy Terms of Use. Create a free personal account to access your subscriptions, sign up for alerts, and more.

Our website uses cookies to enhance your experience.

From toprimary care providers consistently reported that they would recommend Papanicolaou testing sooner than recommended by guidelines, especially after normal co-testing results. Byit had been reduced to 6.

Cervical Cancer Screening Intervals, to Clinical guidelines recommend that women 30 years and older with a negative test result for oncogenic human papillomavirus HPV and with a concurrent normal Papanicolaou test result co-testing not be tested again for at least 3 years. Berkowitz, Saraiya, and Sawaya. However, estimates were weighted to bulleetin population and accounted for survey nonresponse.

ACOG Practice Bulletin Number 131: Screening for cervical cancer.

Purchase access Subscribe to the journal. Cervical cancer is much more common worldwide, particularly in countries without screening programs, with an estimatednew cases of the disease andresultant deaths each year 3, 4.

The highest adherence to guidelines occurred when the recommended interval was less than 3 scrreening, suggesting that clinicians are willing to adhere to guidelines if more vigilant testing is recommended.


Sign in to customize your interests Sign in to your personal account. Using the screening recommendations applicable at the time of the surveys, 1 we defined responses for timing of the next Papanicolaou test as consistent with guidelines; sooner than recommended; and later than recommended Table 1 and Table 2.

A novel benefit of co-testing is the ability to extend screening intervals immediately among women who have no prior screening or whose screening history is unavailable if both test results are normal, yet the lowest adherence to guidelines was for the vignette flr a woman with unknown Papanicolaou test history and negative co-test results 3. Preventive Services Task Force recommendations also has been pracctice 8.

New technologies for cervical cancer screening continue nummber evolve as do recommendations for managing the results. Accessed December 12, Sign in to download free article PDFs Sign in to access your subscriptions Sign in to your personal flr.

Adherence improved when the recommendation was to repeat screening in 1 year because of abnormal results vignettes 4 and 5. However, without a practide Papanicolaou test history vignette 5guideline adherence was low, ranging from Am J Clin Pathol. The ability to obtain prior screening results and the use of electronic medical records or systems changes, such as office reminders or reimbursement packages, may help achieve adherence to recommended intervals. Moving Beyond Annual Testing.

Sign in to save your search Sign in to your personal account. The finding and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. Create a free personal account to download free bullein PDFs, sign up for alerts, and more.

Critical revision of the manuscript for important intellectual content: Vignettes, however, have been shown to be inexpensive and useful tools for measuring quality of care by physicians.


Women’s Health Care Physicians

Each vignette included Papanicolaou test results in the prior 5 years and current HPV and Papanicolaou test results. Uncertain concordance of practitioner response to hypothetical vignette with gor practice might also be of concern. In addition, there are different risk-benefit considerations for women at different ages, as reflected in age-specific screening recommendations. The American Cancer Society ACS estimates that there will be 12, new cases of cervical cancer fof the United States inwith 4, deaths from the disease 2.

Purchase access Subscribe to JN Learning for one year.

Analysis and interpretation of data: Screening for cervical cancer: After normal co-testing results vignettes 2 and 3most respondents Guideline adherence was low overall, especially in vignettes portraying women with normal test results vignettes 1, 2, and 3. Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: Inthe rate was American Cancer Society guideline for the early detection of cervical neoplasia and cancer.

In vignette 4, percentages increased from Sign in to access your subscriptions Sign in to your personal account. Potential cancet in guideline-consistent recommendations between years were compared with t test statistic.

ACOG Updates Cervical Cancer Screening Guidelines

Mortality from the disease has undergone a similar decrease from 5. Future analyses will monitor adherence to newer guidelines that recommend extending screening intervals to 5 years among women with normal co-testing results, a strategy designed to achieve a reasonable balance between benefits and harms.

Get free access to newly published articles Create a personal account or sign in to: